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Background: The full-length membrane protein tyrosine kinase 7 (PTK7) pseudokinase, an important component of
the planar cell polarity and the Wnt canonical and non-canonical pathways, is a subject of step-wise proteolysis in
cells and tissues. The proteolysis of PTK7 involves membrane type-matrix metalloproteinase (MT1-MMP), members
of the Disintegrin Domain and Metalloproteinase (ADAM) family, and γ-secretase. This multi-step proteolysis results
in the generation of the digest fragments of PTK7. These fragments may be either liberated into the extracellular
milieu or retained on the plasma membrane or released into the cytoplasm and then transported into the nucleus.
Results: We employed the genome-wide transcriptional and kinome array analyses to determine the role of the
full-length membrane PTK7 and its proteolytic fragments in the downstream regulatory mechanisms, with an
emphasis on the cell migration-related genes and proteins. Using fibrosarcoma HT1080 cells stably expressing PTK7
and its mutant and truncated species, the structure of which corresponded to the major PTK7 digest fragments, we
demonstrated that the full-length membrane 1–1070 PTK7, the N-terminal 1–694 soluble ectodomain fragment,
and the C-terminal 622–1070 and 726–1070 fragments differentially regulate multiple genes and signaling pathways
in our highly invasive cancer cell model. Immunoblotting of the selected proteins were used to validate the results
of our high throughput assays.
Conclusions: Our results suggest that PTK7 levels need to be tightly controlled to enable migration and that
the anti-migratory effect of the full-length membrane PTK7 is linked to the down-regulation of multiple
migration-related genes and to the activation of the Akt and c-Jun pathway. In turn, the C-terminal fragments of
PTK7 act predominantly via the RAS-ERK and CREB/ATF1 pathway and through the up-regulation of cadherin-11.
In general, our data correlate well with the distinct functionality of the full-length receptor tyrosine kinases and their
respective intracellular domain (ICD) proteolytic fragments.
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Pseudokinase PTK7 is a Wnt co-receptor and an essen-
tial regulator of planar cell polarity (PCP) and directional
cell motility in vertebrate development and embryogen-
esis [1,2]. In humans, the full-length membrane PTK7
consists of seven extracellular immunoglobulin-like (Ig)
domains, a transmembrane region, a juxtamembrane re-
gion and a catalytically inert cytoplasmic tyrosine kinase
domain [3]. The earlier experimental data suggest that* Correspondence: vgolubkov@sanfordburnham.org;
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article, unless otherwise stated.PTK7 directly interacts with β-catenin [4], Wnt proteins
[5,6], plexins and semaphorins [7,8], RACK1 and PKCδ1,
recruits Dishevelled [9,10] and regulates both the non-
canonical Wnt/PCP and canonical Wnt pathways. Be-
cause of severe defects in neural tube closure, mice with
PTK7 truncation died during embryogenesis [1]. Soluble
PTK7 species inhibited angiogenesis by competing with
the full-length PTK7 [11].
In contrast to its well-appreciated, crucial role in ver-
tebrate development, the functional importance of the
intact full-length PTK7 in malignancy is still a matter of
debate. The expression levels of the PTK7 mRNA areed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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myeloid leukemia [12-16]. On the contrary, the levels of
PTK7 are decreased in metastatic melanoma [17] and
breast carcinoma [18]. Deletions of the chromosome
arm 6p, in which the PTK7 gene is localized in humans,
were reported in breast cancer [19] and melanoma [20].
Because pericellular proteolysis plays a primary role in
cell migration, especially in the directional locomotion
of tumor cells, it is likely that proteolysis and PCP con-
verge to promote directed cancer cell migration. In
agreement, the functionality of PTK7 is directly regu-
lated by proteolysis. Ubiquitous membrane type-1 matrix
metalloproteinase (MT1-MMP), arguably the primary
enzyme in pericellular proteolysis and cancer cell migra-
tion, cleaves the PKP621↓LI sequence in the seventh Ig-
like domain of membrane PTK7 and this cleavage results
in the liberation of the N-terminal soluble PTK7 frag-
ment (sPTK7) [21]. MT1-MMP proteolysis is followed
by cleavage of the PEE↓S690 site in the C-terminal re-
sidual portion of PTK7 by ADAMs, including ADAM17.
The ectodomain shedding by MT1-MMP and ADAMs
is a prerequisite for the intramembrane cleavage of
PTK7 by γ-secretase. This cleavage releases the C-
terminal cytoplasmic tail fragment of PTK7 (ICD), which
is then either degraded by the proteasome or trans-
ported to the nucleus [11,22].
The limited pre-existing data suggest that the full-
length membrane PTK7 and its proteolytic products
cause a contrasting effect on the efficiency of cell migra-
tion. Thus, the continuing presence of the full-length
membrane PTK7 on the plasma membrane down-
regulated the myosin light chain (MLC) phosphorylation
(a downstream event of the Wnt/PCP pathway) and also
reduced migration efficiency of fibrosarcoma HT1080
cells [21]. MT1-MMP proteolysis of PTK7 reversed the
inhibitory effect of the full-length membrane PTK7, and
resulted in the accumulation of the Stable N-terminal
sPTK7 fragment in the extracellular milieu and pro-
moted cell invasion of HT1080 cells [11,21,23]. Expres-
sion of the Chz PTK7 mutant that exhibited an
additional PEK↓LK503 MT1-MMP cleavage site in the
junction region between the fifth and the sixth Ig-like
domains stimulated cell migration even further [23].
These effects suggest the existence of the intriguing and
specific downstream mechanisms by which intact PTK7,
its digest fragments and the homo- and heterodimeric
complexes between the PTK7 membrane, soluble and
intracellular portions control cell function. These mech-
anisms, however, have not been precisely investigated in
the earlier works by us and others [11,21-23]. Under-
standing these mechanisms will shed additional light on
the role that PTK7, alone as well as in combination with
MT1-MMP, ADAMs and γ-secretase, plays in cancer cell
migration.In this study, we applied the genome-wide transcrip-
tional and kinome profiling of HT1080 cells to gain
insight into the role of the full-length membrane PTK7,
and its mutant forms and proteolytic fragments in the
downstream signaling and transcriptional events that
directly control the efficiency of cell invasion.
Results
PTK7 in cell invasion
To evaluate in detail the effects of PTK7 and its proteo-
lytic fragments on cell invasion, downstream signaling
and genome-wide transcriptional regulation, we specific-
ally employed fibrosarcoma HT1080 cells. These highly
invasive cells express low endogenous levels of PTK7,
but high levels of active MT1-MMP and ADAMs [11].
Because of these parameters, we could manipulate this
pseudokinase functionality using HT1080 cells trans-
fected with the recombinant PTK7 constructs. The cells
we employed also included the PTK7 knock-out cells
(shPTK7 cells), cells with the enforced overexpression of
the original membrane PTK7 (PTK7 cells) and the
Chuzhoi (Chz) mutant (Chz cells), and, lastly, cells,
which overexpressed multiple truncated species of
PTK7. These species represented the soluble, the mem-
brane and the cytoplasmic digest fragments that were
the result of PTK7 cleavage by MT1-MMP, ADAMs and
γ–secretase (sPTK7, cPTK7/622-1070 and cPTK7/726-
1070 cells) (Figure 1). In addition, because PTK7 func-
tionality is directly linked to MT1-MMP, we isolated
cells in which MT1-MMP was silenced by shRNA
(shMT1 cells). We then co-expressed the shMT1 con-
struct with the Chz mutant (shMT1-Chz cells). Expres-
sion of these constructs in the same cell system allowed
us to determine their downstream effect more precisely.
Our studies revealed that both transcriptional silencing
and overexpression of PTK7 inhibited cell invasion by
~50% relative to the parental cells. In turn, Chz stimu-
lated cell invasion by ~50% (Figure 2). Transcriptional
silencing of MT1-MMP in shMT1-Chz cells reversed
the stimulatory effect of Chz and suppressed cell inva-
sion by ~90%, while MT1-MMP silencing alone (shMT1
cells) was less potent. The effects of sPTK7, cPTK7/622-
1070 and cPTK7/726-1070 were less significant.
Cell microarrays
To elucidate the genome-wide effects of PTK7 in its
mutant and truncated forms, we performed a whole gen-
ome transcriptional analysis of the cells. The differen-
tially expressed genes that exhibited at least a 2-fold
difference relative to the parental cells are shown in
Additional file 1: Table S1. The hierarchical gene cluster-
ing clearly indicated a high similarity among the sPTK7,
Chz and PTK7 samples and, on the other hand, among
the cPTK7/726-1070, cPTK7/622-1070 and shPTK7
Figure 1 PTK7 constructs: 1–1070 PTK7, 1–694 sPTK7, cPTK7/622-1070 and cPTK7/726-1070. S, signal peptide, Ig, immunoglobulin-like
domain, TM, transmembrane domain, JM, juxtamembrane region, KINASE, the catalytically inert kinase domain. The amino acid residue numbering
is shown below the construct structure. MT1-MMP, ADAM and γ-secretase cleavage sites are indicated by arrows. The Chz mutation (Ala-Asn-Pro,
underlined) results in an additional MT1-MMP cleavage site (Pro-Lys-Pro↓Leu622; boxed). FLAG and V5-HIS are the C-terminal tags in the
recombinant constructs.
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expressed genes overlapped in cPTK7/622-1070 and
cPTK7/726-1070 cells. There was a 38.4% overlap be-
tween sPTK7 and Chz, and a overlap 44.5% between the
sPTK7 and PTK7 samples. The data analysis by the IPA
software is described in more detail below.
shPTK7 cells
shPTK7 cells with PTK7 knock-out exhibited up- and
down-regulation of 51 and 52 genes relative to parental
HT1080 cells, respectively. The pro-migratory genes
were either up-regulated (including DCLK1, DMBT1,
FPR1, PPAP2B, NOX4, TRPM2, TGFA, PDE4B and
LIN28B) or down-regulated (including S100A4, CSPG4,
IL8, LPAR1, BGN, SIRPA and GJB2) in shPTK7 cells
(Additional file 2: Table S2). As identified by IPA, Cell-Figure 2 Cell invasion in collagen type I-coated Transwells. The
levels of cell invasion are shown in percent (error bars, S.D.) relative
to the HT1080 cell control ( = 100%). FBS (10%) in the lower
chamber was used as an attractant. Cells were allowed to invade for
3.5 h. The assays were performed in triplicate.to-Cell Signaling and Interaction, and Cellular Move-
ment were the primary molecular and cellular functions
that are likely to be affected in shPTK7 cells.
PTK7 cells
PTK7 cells with the overexpression of the full-length
membrane PTK7 exhibited the up- and down-regulation
of 100 and 247 genes relative to HT1080 cells, res-
pectively. 46 (18%) of the down-regulated genes were
directly linked to cell migration, including HAS2,
LPAR1, TNFRSF21, EDN1, ANXA3, NRG1, S100A4,
GJB2, MAP1B, S1PR1, F3, EZR, SPARC, PLAT, CDH11,
CTSB, TFAP2C, LCP1, NOX4, DCLK1, ITGB1, FABP4,
AFAP1, PPAP2B, CDH2, ITGA2, MMP3, BMP6, PBK,
VCAN, ITGB5, THBS2, CTGF, TGFBI, AJAP1, APP,
CAV1, CSPG4, ARHGEF6, EFNB2, PRMT6, CTSZ,
FNBP1L, MDK, FUT4, and PICK1. In addition, four
anti-migratory genes (EEF1A2, GAD1, CES1 and IL24)
were up-regulated in PTK7 cells (Figure 3C; Additional
file 2: Table S2). Multiple down-regulated pro-migratory
genes are directly linked with focal adhesions and cellu-
lar protrusions, and organization of the actin cytoskel-
eton (JAG1, FERMT2, DPYSL2, LCP1, NFIB, EDN1,
BMP6, SGK1, PLAT, S1PR1, LAMC, CTGF, CAV1,
LPAR1, DCLK1, EZR, CDH2, ITGB1, DAG1, AKAP12,
MAP1B, NEFL and NTNG1). Naturally, the most effected
molecular and cellular functions predicted by the IPA soft-
ware analysis were Cellular Movement, Cell Death and
Survival, Cellular Assembly and Organization, Cell-to-Cell
Signaling and Interaction, and Cellular Development. The
affected gene pattern suggested that multiple pathways are
likely to be suppressed such as CREBBP, WNT3A,
CTNNB1 and TP53. Overall, the data suggest that the
Figure 3 Genome-wide transcriptional profiling. A. Heat map and the hierarchical clustering of the expression data (log2 of expression level) of
the differentially expressed genes in PTK7, sPTK7, Chz, cPTK7/726-1070, cPTK7/622-1070 and shPTK7 cells relative to the parental HT1080 cells. Red and
green correspond to the high and the low expression levels, respectively (color bar inset). B. The number of differentially expressed genes in the
samples. Numbers show the number of the up-regulated (red) and the down-regulated (green) genes relative to HT1080 cells. C. Heat map and the
hierarchical clustering of the expression data (log2 of expression level) of the differentially expressed, cell motility-related genes in the cells (selected
using the IPA software) relative to HT1080 cells (Additional file 2: Table S2). Red and green correspond to the high and the low expression levels,
respectively (color bar inset). D. Expression level validation of the selected up-regulated genes by immunoblotting. Top two panels, PTK7 was analyzed
using the PTK7 antibody in the total cell lysates (total) and the cell surface-biotinylated cell samples (surface). Bottom panel, The FLAG- and V5-tagged
recombinant PTK7 constructs were analyzed using the FLAG and V5 antibodies (total cell lysate samples), respectively. CDH11, cadherin-11; SPP1,
osteopontin; IL1B, interleukin 1β; PDPN, podoplanin; MAGEC1, melanoma antigen family C1. The numbers above the protein bands show the
fold-difference of the differentially expressed genes as detected by transcriptional profiling. Tubulin, loading control.
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associated genes plays a significant role in the anti-
migratory function of the full-length membrane PTK7.Chz cells
In Chz cells, 210 and 58 genes were up- and down-
regulated relative to HT1080 cells, respectively. In sharp
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genes were pro-migratory (IL1B, IL1A, PLAT, HSPB1,
ABCA1, SERPINB2, NUCB2, EGR1, WNT5A, SUMO1,
S1PR1, LAMB1, TGFA, KPNA2, MYO10, PTPN12,
PARP9, AJAP1, MYH9, MIA, ETS1, NREP, CD44,
HMGB1, SDCBP, EPHB1, ITGA6, TM4SF1, GSN, and
ALCAM) (Figure 3C; Additional file 2: Table S2). Fur-
thermore, NDRG2 and FOXA2, which are negative
regulators of cell motility, were down-regulated. In
agreement, Cellular Movement, Cellular Growth and
Proliferation, Cell-to-Cell Signaling and Interaction, Cell
Cycle, Cell Death and Survival were recognized as the
most probable enhanced molecular and Cellular func-
tions in Chz cells. Up-regulation of these cellular func-
tions is likely to involve activation of the IL1B, EGF,
RAF1 and down-regulation of the DKK1 pathways.
sPTK7 cells
59 and 105 genes were up- and down-regulated in
sPTK7 cells, respectively. The pro-migratory genes were
either up-regulated (including IL1B and CCL3) or
down-regulated (including CDH11, MMP9, DCLK1,
AJAP1) in sPTK7 cells (Figure 3C; Additional file 2:
Table S2). The affected molecular and cellular functions
predicted by the IPA were Cell-to-Cell Signaling and
Cellular Movement.
cPTK7/726-1070 cells
These cells expressed the C-terminal 726–1070 mem-
brane fragment that is generated by γ-secretase cleavage
of PTK7 and that can be either degraded or transported
into the nucleus [11]. 39 and 127 genes were up- and
down-regulated in cPTK7/726-1070 cells as compared
with HT1080 cells, respectively. The pro-migratory
genes were either up-regulated (including CDH11,
MMP3 and DCLK1) or down-regulated (including
DKK3, CAV1, CDH2, MMP9, ATF3 and DSTN) in
cPTK7/726-1070 cells (Figure 3C; Additional file 2:
Table S2). The IPA-predicted pathways involved HRAS
and KRAS, FGF1, PI3K, MAP2K1, TGFβ, RAC1, MYCN,
while Cell Morphology, Cellular Movement, Cell Death
and Survival, Cellular Development, Cellular Growth
and Proliferation represented the predicted molecular
and cells functions.
cPTK7/622-1070 cells
Only 22 and 9 genes were up- and down-regulated, re-
spectively. As a result, statistically relevant data analysis
was not possible in these cells. The top up-regulated
gene was cadherin-11 (CDH11).
Validation of the microarray data by immunoblotting
In our immunoblotting studies, the use of goat and
rabbit antibodies against the N- and C-terminal portionsof PTK7, respectively, and also the V5 and FLAG anti-
bodies allowed us to discriminate the naturally expressed
PTK7 from the recombinant tagged constructs. This
analysis confirmed the efficient PTK7 silencing in
shPTK7 cells (Figure 3D). Both the naturally expressed
and overexpressed PTK7 were efficiently presented at
the cell surface in HT1080 and PTK7 cells, respectively.
Consistent with our earlier data [23], the cell surface
levels of Chz were low because of its efficient shedding
by MT1-MMP. Cell surface endogenous PTK7 levels
were relatively low in both sPTK7 and cPTK7/726-1070
cells, suggesting that the recombinant constructs af-
fected the cell surface presentation of the full-length
membrane pseudokinase. Immunoblotting with the
FLAG antibody confirmed that there were the compar-
able levels of expression of the PTK7, sPTK7 and Chz
constructs in the respective cells. Immunoblotting with
the V5 antibody demonstrated the proteolysis of the
cPTK7/622-1070 construct. As a result of this proteoly-
sis, the cPTK7/622-1070 construct was partially con-
verted into the γ-secretase-dependent species similar to
cPTK7/726-1070.
We then employed immunoblotting to validate the
levels of the selected genes, up- and down-regulation of
which was detected by the genome-wide transcriptional
profiling of the respective cells. Thus, the cadherin-11
(CDH11) gene expression was up-regulated 3.9- and 6-
fold in cPTK7/622-1070 and cPTK7/726-1070 cells, re-
spectively, and down-regulated 2.9-fold in both PTK7
and sPTK7 cells. In agreement, cadherin-11 protein was
significantly elevated in cPTK7/622-1070 and cPTK7/
726-1070 cells, and decreased in PTK7 and sPTK7 cells.
Cadherin-11 plays an important role in osteogenesis,
epithelial-to-mesenchymal transition and bone metasta-
sis [24-26], and is functionally linked to osteopontin
(SPP1), a bone-specific protein. In agreement, the levels
of osteopontin increased in cPTK7/622-1070, cPTK7/
726-1070 and Chz cells relative to other cell types.
According to the microarray data, IL1B was up-
regulated 12.8-, 5- and 5-fold in Chz, PTK7 and sPTK7
cells, respectively. In agreement, immunoblotting re-
corded a significant IL1B increase in PTK7, sPTK7 and
Chz cells. An inflammatory IL1B cytokine is involved in
cancer onset and progression [27,28].
Our microarray results suggested that podoplanin
(PDPN) was up-regulated 13-fold in sPTK7 cells. In
agreement, our immunoblotting studies revealed that
the PDPN expression was greatly elevated in sPTK7
compared with other cell types. PDPN, a mucin-type
transmembrane protein, is important to embryo devel-
opment and epithelial-to-mesenchymal transition. PDPN
is frequently upregulated in metastatic cancers to induce
RhoA activity and promote cell migration and invasion
[29-31]. In agreement, our previous data suggest that
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tially, via the PDPN-dependent mechanism [21].
As the microarray data demonstrated, MAGEC1 (mel-
anoma antigen family C1) expression was up-regulated
14-fold in PTK7 cells. Consistently, the MAGEC1 levels
were elevated in PTK7 cells. MAGEC1 belongs to cancer/
testis (CT) antigen family. The expression of MAGEC1 is
frequently elevated in a variety of cancers [32,33].
Phospho-kinase array
To get a deeper insight into the PTK7-dependent regula-
tion of cell signaling, we employed the Proteome Profiler
Human Phospho-Kinase Array. The use of this array
permits a comparative analysis of 43 kinase phosphoryl-
ation sites.
Our array data suggested that the PTK7 transcriptional
silencing decreased phosphorylation of p38a (T180/Y182),
ERK1/2 (T202/Y204, T185/Y187), Akt (S473, T308), c-Jun
(S63) and CREB (S133) in shPTK7 cells and increasedFigure 4 Protein phosphorylation profiling. A. Top panel, Protein phosp
(S473), CREB (S133), β-catenin protein, p53 (S15) and c-Jun (S63) in HT1080
shMT1-Chz and shMT1 cells. The spots were scanned and digitized. Pixel d
B. A representative array of the HT1080 cell sample. The spots (boxed) of p
β-catenin protein, p53 (S15) and c-Jun (S63) are numbered. C. Western blo
shPTK7, PTK7, sPTK7, cPTK7/622-1070, cPTK7/726-1070, Chz, shMT1-Chz andphosphorylation of p53 (S15) relative to the HT1080 cell
control transfected with the scrambled shRNA construct
(Figure 4). The levels of β-catenin were also decreased. A
decrease in phosphorylation of c-Jun (S63) and in the β-
catenin protein levels were recorded in sPTK7 cells.
A significant increase in phosphorylation of CREB
(S133) and a decrease in p38a (T180/Y182) and c-Jun
(S63) were recorded in cPTK7/726-1070 cells. In a way
that is similar with cPTK7/726-1070 cells, enhanced and
repressed phosphorylation of CREB (S133) and c-Jun
(S63) were the characteristic features of cPTK7/622-
1070 cells, respectively. In shMT1-Chz cells, the most
evident was the reduced phosphorylation of ERK1/2
(T202/Y204, T185/Y187) and p53 (S15) relative to Chz
and shMT1 cells. On the contrary, the levels of phos-
phorylated Akt (S473, T308) and c-Jun (S63) and of the
total β-catenin protein increased in shMT1-Chz cells.
To corroborate the kinome array data, we analyzed the
levels of p-c-Jun (S63) and p-CREB (S133) in the totalhorylation profiling of p38a (T180/Y182), ERK1/2 (T202/Y204), Akt 1/2/3
-scr, shPTK7, PTK7, sPTK7, cPTK7/622-1070, cPTK7/726-1070, Chz,
ensity of the spots is shown by the graphs in the bottom panel.
38a (T180/Y182), ERK1/2 (T202/Y204), Akt 1/2/3 (S473), CREB (S133),
tting of phosphorylated and total cell c-Jun, CREB and ATF1 in HT1080,
shMT1 cells.
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622-1070, cPTK7/726-1070, Chz, shMT1-Chz and
shMT1 cells (Figure 4C). We also determined levels of
ATF1, a transcription factor closely related to CREB. In
agreement with the kinome array data, p-c-Jun phos-
phorylation was enhanced in PTK7 cells as compared
with HT1080 cells, and also in shMT1-Chz cells relative
to shMT1 cells. In addition, we recorded an increase in
p-CREB (S133) and p-ATF1 (S63) in cPTK7/622-1070
and cPTK7/726-1070 cells as compared with other cells.
To further support the increased levels of β-catenin we
observed in the kinome array in PTK7 cells, we per-
formed immunostaining of HT1080 and PTK7 cells. As
expected, the increased β-catenin immunoreactivity at
the cell-to-cell contacts was readily observed in PTK7
cells but not in HT1080 cells (Figure 5).
The data, especially when combined, led us to con-
clude that the N-terminal ectodomain and the C-
terminal cytoplasmic portions differentially regulate
multiple signaling pathways. The summary of our data
and the predicted regulatory signaling pathways are pre-
sented in Figure 6.
Discussion
Pseudokinase PTK7, a functionally important regulator
of Wnt pathways [1-6], is a subject of the multi-step pro-
teolysis in multiple cell/tissue types [11,21-23]. PTK7
levels need to be tightly controlled to enable migration of
HT1080 cancer cells. The full-length membrane PTK7
has a pronounced anti-migratory effect in HT1080 cells
while its proteolysis reverses this anti-migratory effect
and facilitates cell locomotion. The recent data suggest
that proteolysis of the full-length membrane PTK7 in-
volves MT1-MMP, ADAMs and γ-secretase [11,21-23].
The resulting multiple and stable digest fragments of
PTK7 may be either liberated into the extracellular mi-
lieu or retained on the plasma membrane or released intoFigure 5 Immunostaining of β-catenin in HT1080 and PTK7 cells. Cells
cytoskeleton was stained using Alexa Fluor 594-conjugated phalloidin. DAP
accumulation in the cell-to-cell contacts in PTK7 cells.the cytoplasm and then transported into the nucleus. We
hypothesized that certain PTK7 fragments display a dis-
tinct, albeit currently unknown, function relative to intact
PTK7. To test this hypothesis, we employed fibrosarcoma
HT1080 cells, which expressed the full-length membrane
PTK7 or its truncated and mutant forms that corre-
sponded to the PTK7 digest fragments. We also used the
cells in which PTK7 and MT1-MMP were transcription-
ally silenced. The analysis of PTK7 expression suggests
that the PTK7 proteolytic fragments modulate the full-
length PTK7 cell surface presentation and function.
We demonstrated that MT1-MMP silencing in
shMT1-Chz cells inhibited proteolytic processing of the
Chz mutant and both induced accumulation of the full-
length Chz at the cell surface and markedly reduced cell
invasion [11]. Thus, we used the shMT1-Chz cells to re-
veal the signaling by the stabilized full-length PTK7.
Based on the phospho-kinase array analysis of shMT1-
Chz cells, we now suggest that the stabilized full-length
PTK7 up-regulates Akt and c-Jun signaling. It is well
documented that Akt regulates cellular survival path-
ways, inhibits GSK3 and modulates Wnt signaling
[34,35]. c-Jun is a proto-oncogene that represses p53
transcription, protects cells from apoptosis and induces
cell cycle progression [36]. In agreement, the levels of
p53 (S15) were reduced while the levels of β-catenin
were elevated in shMT1-Chz cells. It was also demon-
strated by others that PTK7 silencing induced apoptosis
in colon cancer HCT-116 cells, reinforcing that PTK7
regulates cell survival [37].
Furthermore, our analysis of the signaling pathways
predicted that WNT3A and CTNNB1 (β-catenin) were
inhibited in PTK7 cells, suggesting that β-catenin was
stabilized by PTK7 and was not efficiently translocated
into the cell nucleus. The recent study that documented
direct interactions between PTK7 and β-catenin sup-
ports our data [4]. In agreement, our results indicatedwere stained using the β-catenin monoclonal antibody. The actin
I, the nuclei. Arrows indicate the β-catenin immunoreactivity
Figure 6 PTK7 signaling. The pathways and the key proteins are predicted based on the results of our genome-wide transcriptional and protein
phosphorylation profiling. Our data suggest that the stabilized full-length membrane PTK7 up-regulates the Akt and c-Jun pathways, and
down-regulates the p53 pathways leading to the cell survival signaling. Full-length PTK7 also suppresses ERK and CREB-mediated gene expression
and cell motility. The proteolysis of PTK7 ectodomain (Ig1-Ig7) by MT1-MMP and ADAMs generates the soluble sPTK7 form. The subsequent
cleavage of the C-terminal membrane PTK7 fragment by γ-secretase releases the intracellular domain (cPTK7). The soluble sPTK7 species binds the
full-length membrane PTK7 and activates the RhoA [21] and p38a pathways, which regulate the actin cytoskeleton and the expression of the
migratory genes, including IL1B. The intracellular PTK7 domain fragment, cPTK7, enters the cell nucleus and induces the RAS/p90RSK/CREB
signaling resulting in the CREB and ATF1 phosphorylation at Ser133 and Ser63, respectively, and the expression of the pro-migratory genes,
including cadherin-11 (CDH11). We hypothesize that the ratio of the full-length membrane PTK7 to the N-terminal and the C-terminal PTK7
proteolytic fragments acts as a switch, which establishes the downstream signaling pathways that control cell survival and motility.
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the cell-to-cell junctions in PTK7 cells. Interestingly, the
sPTK7 construct reduced both the level of phosphory-
lated c-Jun (S63) and the β-catenin level, suggesting an
antagonistic role of sPTK7 relative to the full-length
PTK7. We hypothesize that the c-Jun activity is specific-
ally induced by the intact full-length PTK7. On the con-
trary, both C-terminal PTK7 forms reduced the levels of
c-Jun (S63) and induced phosphorylation of CREB
(S133) and ATF1 (S63), a transcription factor similar to
CREB. Phosphorylation at Ser133 activates the CREB
transcriptional activity [38,39]. In agreement, our IPA
analysis of the differentially expressed genes in cPTK7/
726-1070 cells predicted the activation of HRAS, KRAS
and FGF1, the upstream pathways that control CREB ac-
tivity [40]. Overall, it is likely that MT1-MMP proteoly-
sis of PTK7, ADAM and γ-secretase promotes cancer
progression by stimulating the CREB activity. Notably,
CREB activity is elevated in metastatic cancers [41,42]
and essential to embryo development and neurogenesis
[43]. It is tempting to hypothesize that the activation ofCREB by the C-terminal PTK7 fragments contributes to
both normal embryogenesis and cancer. CREB activity is
also regulated by CREB-binding protein (CBP or
CREBBP). Consistently, our gene array analysis predicted
the down-regulation of the CREBBP pathway in PTK7
cells, suggesting further that the CREB pathway is differ-
entially regulated by the full-length PTK7 and the C-
terminal PTK7 fragments.
In addition, the C-terminal PTK7 species up-regulated
cadherin-11 (also called OB-cadherin), a calcium-
dependent cell-cell adhesion molecule and a mesenchy-
mal cell marker [24]. Cadherin-11 is expressed in the
mesoderm-derived tissues, associated with the epithelial-
to-mesenchymal transition, and regulates osteogenesis
[25] and cancer metastasis to the bone [26]. Cadherin-11
is also involved in cell migration in embryogenesis
[24,25,32]. It is likely that PTK7 and cadherin-11 interact
in embryogenesis and regulate similar developmental
processes. Furthermore, PTK7 and cadherin-11 are pre-
dicted to be co-expressed by the CoexpressDB open
source software.
Golubkov and Strongin Cell Communication and Signaling 2014, 12:15 Page 9 of 12
http://www.biosignaling.com/content/12/1/15Conclusions
Overall, by using genome-wide transcriptional and
phospho-kinase profiling of the cell samples, we deter-
mined that the full-length membrane PTK7 and its
N-terminal and C-terminal proteolytic fragments differ-
entially regulate multiple genes and proteins involved in
cell motility. These differences were most evident in the
phosphorylation levels of p38a, ERK, Akt, c-Jun, CREB,
ATF1, p53, and in the β-catenin and cadherin-11 protein
levels. Our data correlate well with the results in other
receptor tyrosine kinases and support the general idea
about the distinct functions of the full-length receptor
and its intracellular domain (ICD) fragment [44]. The re-
sults generated from our model system will shed more




General reagents were purchased from Sigma-Aldrich
(Saint Louis, MO, USA). A goat polyclonal AF4499 anti-
body against the N-terminal 31–199 portion of PTK7, a
goat polyclonal antibody to IL1B and a rabbit polyclonal
antibody to pCREB (S133) were from R&D Systems
(Minneapolis, MN, USA). A mouse monoclonal antibody
to the V5 tag was from Invitrogen (Carlsbad, CA, USA)
A mouse monoclonal M2 antibody to the FLAG tag was
from Sigma-Aldrich. The rabbit polyclonal antibodies to
cadherin-11 (CDH11, OB-cadherin) and α-tubulin,
rabbit monoclonal antibodies to CREB, podoplanin and
p-c-Jun (S63), and a mouse monoclonal antibody to c-
Jun were from Cell Signaling Technology (Danvers, MA,
USA). A rabbit monoclonal antibody to p-ATF1 (S63)
was from Abcam (Cambridge, MA, USA). The mouse
monoclonal antibodies to osteopontin (SPP1) and
MAGEC1 were from EMD Millipore (Temecula, CA,
USA) and Santa Cruz Biotechnology (Dallas, TX, USA),
respectively. The species-specific HRP-conjugated second-
ary antibodies were from Fitzgerald Industries (Acton,
MA, USA).
Cells, cloning and mutagenesis
Human fibrosarcoma HT1080 cells (HT1080 cells) were
from ATCC (Manassas, VA, USA). HT1080 cells trans-
fected with the full-length 1–1070 PTK7 containing the
C-terminal FLAG tag (PTK7 cells), the N-terminal 1–694
fragment with the C-terminal FLAG tag (sPTK7
cells) and the C-terminal 726–1070 fragment with the
V5-HIS tag (cPTK7/726-1070 cells) were described earl-
ier [11,21,23]. Cells in which the transcription of the
MT1-MMP gene was silenced using the shRNA con-
struct (shMT1 cells) were characterized earlier [11,45].
The C-terminal 622–1070 membrane fragment (cPTK7/
622-1070 cells) that corresponded to the MT1-MMPcleavage fragment of the full-length membrane PTK7
was generated by PCR using the full-length wild-type
PTK7-1 cDNA (OriGene, Rockville, MD, USA) as a tem-
plate, and 5′-GGTACCCAGACAGCCCTGATTCAGTG
GAAAGG-3′ and 5′-CGGCTTGCTGTCCAC-3′ as the
forward and reverse primers, respectively. The 1–30
PTK7 signal peptide sequence was amplified using 5′-
CACCATGGGAGCTGCGCGGGGATC-3′ and 5′-CCT
TTCCACTGAATCAGGGCTGTCTGGGTACC-3′ as the
forward and reverse primers, respectively, and then the
signal peptide sequence was inserted at the N-terminus
to ensure delivery of the cPTK7/622-1070 construct to
the plasma membrane. The resulting secretory cPTK7/
622-1070 construct was sub-cloned into the pcDNA3.1D/
V5-His-TOPO vector (Invitrogen) and then used to sta-
bly transfect HT1080 cells using Lipofectamine LTX
(Invitrogen). Stably transfected cells were selected in the
presence of G418 (200 μg/ml). Cell expression of the
cPTK7/622-1070 construct was confirmed using Western
blotting with the V5 antibody.
The 29-mer shRNA constructs in the retroviral RFP vec-
tor (pRFP-C-RS) (Origene; catalog number TF200451)
were used to silence the endogenous PTK7 in HT1080
cells. Following Lipofectamine LTX transfection of the
cells with the vector, the RFP-positive cells were selected
using a cell sorter. Selected cells were then grown in the
presence of puromycin (2 μg/ml). Immunoblotting with
the goat polyclonal PTK7 antibody was used to select the
silenced clones. Three selected clones with the silenced
PTK7 were pooled together (shPTK7 cells). Similarly, the
scrambled shRNA constructs were used to generate the
HT1080-scr cell control.
Invasion assay
The invasion assay was performed in triplicate in wells of
a 24-well Transwell plate with an 8-μm pore size mem-
brane [11]. The membranes of the Transwell inserts were
coated with type I collagen (30 μg/well, BD Biosciences,
San Jose, CA, USA). Cells (1 × 105/well) in serum-free
DMEM (0.1 ml) were placed into the upper chamber. The
10% fetal bovine serum (FBS)-containing DMEM (used as
a chemoattractant, 0.6 ml) was placed in the lower cham-
ber. Serum-free DMEM (0.6 ml) was used as a control.
Cells were allowed to invade for 3.5 h. The cells were
stained for 10 min with 0.2% crystal violet/20% methanol
(0.3 ml). The cells on the upper membrane surface were
removed with a cotton swab. The dye from the cells that
migrated onto the lower surface of the membrane was ex-
tracted with 1% SDS (0.25 ml). The resulting A570 nm
was measured using a plate reader.
Genome-wide transcriptional profiling and data analysis
Cells (1 × 104/ml) were plated in DMEM-10% FBS
in a 100-mm dish and grown for 72 h to produce a
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using a Direct-zol RNA MiniPrep kit (Zymo Research,
Irvine, CA, USA). Biotin-labeled cRNA samples were
prepared using an RNA Amplification Kit (Life Tech-
nologies, Grand Island, NY, USA). The labeled cRNA
(750 ng) was hybridized for 18 h at 58°C to the
HumanHT-12 v4 Expression BeadChip with over 46,000
gene transcripts (Illumina, San Diego, CA, USA). Bead-
Chips were then developed using fluorolink streptavidin-
Cy3 (GE Healthcare, Piscataway, NJ, USA). Array chips
were scanned using an Illumina BeadArray Reader. The
initial data extraction and normalization were performed
using the BeadArray Reader and GeneSpring GX soft-
ware (Agilent, Santa Clara, CA, USA). The differentially
expressed genes (compared to parental HT1080 cells)
were identified based on the Welch’s t test and -fold dif-
ference of the expression level (cutoff >2-fold difference,
p-value <0.05). Heatmaps and hierarchical clustering
were generated using the GenePattern open-source soft-
ware package (Broad Institute, Cambridge, MA, USA).
The pathway and functional analyses were conducted
using the Ingenuity Pathway Analysis (IPA) software (In-
genuity Systems, Redwood City, CA, USA). The micro-
array data were deposited to the Gene Expression
Omnibus (GEO) data base with the accession number
GSE53340.
Human phospho-kinase array
The phosphorylation profile was analyzed in the cells
using the Proteome Profiler Human Phospho-Kinase
Array (R&D Systems). Cells (1 × 104/ml) were plated in
DMAM-10% FBS in a 100-mm dish and grown for 72 h
to produce a subconfluent culture. Cell lysate samples
(0.5 mg; 1.5 mg/ml each) were applied per array set
comprised of two nitrocellulose membranes with the
spotted capture antibodies. The bound material was de-
tected using the biotinylated antibodies followed by
streptavidin conjugated with horseradish peroxidase.
The chemiluminescent signal was acquired using the
HyBlot CL autoradiography film (Denville, South Plain-
field, NJ, USA). The film was scanned and digitized.
Pixel density of the spots was quantified using the Ima-
geJ software.
Cell surface biotinylation and total cell lysates
Cell surface proteins were biotinylated by incubating
cells for 1 h on ice in PBS containing 0.1 mg/ml EZ-
Link sulfosuccinimidyl 2-(biotinamido)-ethyl-1,3-dithio-
propionate (Thermo Fisher Scientific, Rockford, IL,
USA). Cells were lysed in 20 mM Tris–HCl buffer,
pH 7.4, containing 150 mM NaCl, 1% deoxycholate, 1%
octylphenoxypolyethoxyethanol (IGEPAL), protease in-
hibitor mixture set III, 1 mM phenylmethylsulfonyl
fluoride and 10 mM EDTA. Biotinylated proteins werethen captured using streptavidin-agarose beads. Biotinyl-
ated proteins were eluted from the beads using 2X SDS
sample loading buffer (125 mM Tris–HCl, pH 6.8, con-
taining 4% SDS, 0.005% bromophenol blue, 20% glycerol
and 20 mM DTT).
For preparation of the total cell lysate samples, cells
were lysed using the cell lysis buffer of the Proteome Pro-
filer Human Phospho-Kinase Array kit (R&D Systems).
The samples were centrifuged at 4°C (14,000 rpm,
15 min). The protein concentration in the supernatant
samples was adjusted to 1.5 mg/ml. The sample aliquots
(30 μg total protein each) were separated by SDS-gel elec-
trophoresis in the 4-12% gels and analyzed by immuno-
blotting with the specific primary antibodies followed by
the horseradish peroxidase-conjugated species-specific
secondary antibody and the SuperSignal West Dura ex-
tended duration substrate (Thermo Fisher Scientific). The
chemiluminescent signal was acquired using the HyBlot
CL autoradiography film.
Cell immunostaining
Cells grown on a microscope coverglass (Thermo Fisher
Scientific) were fixed using 4% p-formaldehyde, perme-
abilized using 0.1% Triton X-100, and blocked in 1% ca-
sein. Cells were stained using the primary monoclonal
mouse antibody to β-catenin (1:1,000 dilution) (Becton
Dickinson, Franklin Lakes, NJ, USA) for 16 h at 4°C
followed by Alexa Fluor 488-conjugated anti-mouse sec-
ondary antibody (1:500 dilution). The Alexa Fluor 594-
conjugated phalloidin (1:500 dilution) (Thermo Fisher
Scientific) was used to visualize the actin cytoskeleton.
The specimens were mounted in the Vectashield mount-
ing medium with 4′,6-diamidino-2-phenylindole (DAPI)
(Vector Laboratories, Burlingame, CA, USA). Images
were acquired using an Olympus BX51 fluorescence
microscope equipped with a MagnaFire digital camera
and MagnaFire 2.1C software (Olympus, Center Valley,
PA, USA).
Additional files
Additional file 1: Table S1. Genome-wide transcriptional profiling of
Chz, shPTK7, cPTK7/622-1070, cPTK7/726-1070, sPTK7 and PTK7 cells
relative to the parental fibrosarcoma HTR1080 cells.
Additional file 2: Table S2. Genome-wide transcriptional profiling
of the cell migration-related genes in Chz, shPTK7, cPTK7/622-1070,
cPTK7/726-1070, sPTK7 and PTK7 cells relative to the parental
fibrosarcoma HTR1080 cells.
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